The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.
The global Autoimmune Drugs market was valued at US$ 2242.3 million in 2023 and is anticipated to reach US$ 2949.9 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North American market for Autoimmune Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Autoimmune Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Autoimmune Drugs include Eli Lilly, GSK, AbbVie, Johnson & Johnson, Biogen, Amgen, Pfizer, Roche and Baxter, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Drugs.
Report Scope
The Autoimmune Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Eli Lilly
- GSK
- AbbVie
- Johnson & Johnson
- Biogen
- Amgen
- Pfizer
- Roche
- Baxter
Segment by Type
- Rheumatoid Arthritis (RA)
- Multiple Sclerosis (MS)
- Psoriasis
- Inflammatory Bowel Disease (IBD)
- Ankylosing Spondylitis (AS)
- Systemic Lupus Erythematosus (SLE)
Segment by Application
- Hospitals
- Homecare
- Specialty Clinics
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Autoimmune Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Autoimmune Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Autoimmune Drugs Market Overview
1.1 Product Overview and Scope of Autoimmune Drugs
1.2 Autoimmune Drugs Segment by Type
1.2.1 Global Autoimmune Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Rheumatoid Arthritis (RA)
1.2.3 Multiple Sclerosis (MS)
1.2.4 Psoriasis
1.2.5 Inflammatory Bowel Disease (IBD)
1.2.6 Ankylosing Spondylitis (AS)
1.2.7 Systemic Lupus Erythematosus (SLE)
1.3 Autoimmune Drugs Segment by Application
1.3.1 Global Autoimmune Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.4 Global Autoimmune Drugs Market Size Estimates and Forecasts
1.4.1 Global Autoimmune Drugs Revenue 2019-2030
1.4.2 Global Autoimmune Drugs Sales 2019-2030
1.4.3 Global Autoimmune Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Autoimmune Drugs Market Competition by Manufacturers
2.1 Global Autoimmune Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Autoimmune Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Autoimmune Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Autoimmune Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Autoimmune Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autoimmune Drugs, Product Type & Application
2.7 Autoimmune Drugs Market Competitive Situation and Trends
2.7.1 Autoimmune Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Autoimmune Drugs Players Market Share by Revenue
2.7.3 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autoimmune Drugs Retrospective Market Scenario by Region
3.1 Global Autoimmune Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Autoimmune Drugs Global Autoimmune Drugs Sales by Region: 2019-2030
3.2.1 Global Autoimmune Drugs Sales by Region: 2019-2024
3.2.2 Global Autoimmune Drugs Sales by Region: 2025-2030
3.3 Global Autoimmune Drugs Global Autoimmune Drugs Revenue by Region: 2019-2030
3.3.1 Global Autoimmune Drugs Revenue by Region: 2019-2024
3.3.2 Global Autoimmune Drugs Revenue by Region: 2025-2030
3.4 North America Autoimmune Drugs Market Facts & Figures by Country
3.4.1 North America Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Autoimmune Drugs Sales by Country (2019-2030)
3.4.3 North America Autoimmune Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Autoimmune Drugs Market Facts & Figures by Country
3.5.1 Europe Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Autoimmune Drugs Sales by Country (2019-2030)
3.5.3 Europe Autoimmune Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autoimmune Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Autoimmune Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Autoimmune Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Autoimmune Drugs Market Facts & Figures by Country
3.7.1 Latin America Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Autoimmune Drugs Sales by Country (2019-2030)
3.7.3 Latin America Autoimmune Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autoimmune Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Autoimmune Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Autoimmune Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Autoimmune Drugs Sales by Type (2019-2030)
4.1.1 Global Autoimmune Drugs Sales by Type (2019-2024)
4.1.2 Global Autoimmune Drugs Sales by Type (2025-2030)
4.1.3 Global Autoimmune Drugs Sales Market Share by Type (2019-2030)
4.2 Global Autoimmune Drugs Revenue by Type (2019-2030)
4.2.1 Global Autoimmune Drugs Revenue by Type (2019-2024)
4.2.2 Global Autoimmune Drugs Revenue by Type (2025-2030)
4.2.3 Global Autoimmune Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Autoimmune Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Autoimmune Drugs Sales by Application (2019-2030)
5.1.1 Global Autoimmune Drugs Sales by Application (2019-2024)
5.1.2 Global Autoimmune Drugs Sales by Application (2025-2030)
5.1.3 Global Autoimmune Drugs Sales Market Share by Application (2019-2030)
5.2 Global Autoimmune Drugs Revenue by Application (2019-2030)
5.2.1 Global Autoimmune Drugs Revenue by Application (2019-2024)
5.2.2 Global Autoimmune Drugs Revenue by Application (2025-2030)
5.2.3 Global Autoimmune Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Autoimmune Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly Autoimmune Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Autoimmune Drugs Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AbbVie Autoimmune Drugs Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Autoimmune Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Biogen
6.5.1 Biogen Corporation Information
6.5.2 Biogen Description and Business Overview
6.5.3 Biogen Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biogen Autoimmune Drugs Product Portfolio
6.5.5 Biogen Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amgen Autoimmune Drugs Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Autoimmune Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche Autoimmune Drugs Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Baxter Autoimmune Drugs Product Portfolio
6.9.5 Baxter Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autoimmune Drugs Industry Chain Analysis
7.2 Autoimmune Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autoimmune Drugs Production Mode & Process
7.4 Autoimmune Drugs Sales and Marketing
7.4.1 Autoimmune Drugs Sales Channels
7.4.2 Autoimmune Drugs Distributors
7.5 Autoimmune Drugs Customers
8 Autoimmune Drugs Market Dynamics
8.1 Autoimmune Drugs Industry Trends
8.2 Autoimmune Drugs Market Drivers
8.3 Autoimmune Drugs Market Challenges
8.4 Autoimmune Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
